Forecasting Diabetes : Jardiance , Trajenta & BasaglarPipeline Forecast CNS & Immunology

Patient based forecasting of launched products : Plavix, Lovenox, Multaq, Taxotere, Eloxatin, Aprovel, Lemtrada, Aubagio and some biosurgery and rare disease (Fabry, ...) Patient based forecasting of products in development : SPAF, DVT/PE, anti-platelets , OAB, alzheimer, parkinson, antibiotics, PCSK9 , depression, tuberculosis , dengue, psoriasis, osteoporosis scleroderma, cystic fibrosis, pain , sleeping disorders, ophthalmology, sarcopenia, hearing disorders, CKD ....M&A forecasting: Genzyme & some smaller BDL in areas like HCVDevelopment of simple tools to forecast fast multi indications incl. risk assessment & NPV calculationTraining & challenge of local forecastingAnalog analysis of global brands to identify success factors for strategy development e.g lifecycle management , end of patent , phase IV trials, combo products ...Living the motto : Forecast is the translation of the strategy into numbers